Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nevro Corp (NVRO – Research Report), Globus ...

JMP Securities analyst Patrick Walravens maintained a Buy rating on Vertex (VERX – Research Report) today and set a price target of $61.00. The ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Vertex Pharmaceuticals is flexing its innovation muscles beyond its cystic fibrosis stronghold, charging into new territories ...

Researchers have shed new light on how a type of heart valve disease -- aortic valve stenosis -- progresses differently in males and females.

The Leapfrog Group, an independent national nonprofit calling for better and safer patient care, today released its 2025 ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharmaceuticals is marching beyond its cystic fibrosis stronghold with bold steps into pain management and genetic ...

ZILLOW GONE WILD: “A government contractor and lobbyist who served in President Donald Trump’s first administration bought Vice President JD Vance ’s Virginia home in an above-market deal, a sale his ...

The Israeli spyware company blacklisted over human rights concerns has hired the firm to provide strategic advice on cyber policy issues.

The growing lineup of upcoming Xbox Series X games on the way speaks to some very exciting times ahead. With lots of highly anticipated releases just around the corner, and more notable future ...